Erle S. Robertson
Affiliations: | University of Michigan, Ann Arbor, Ann Arbor, MI |
Area:
Microbiology Biology, Cell Biology, Molecular BiologyGoogle:
"Erle Robertson"Children
Sign in to add trainee| Murray A. Cotter | grad student | 2003 | University of Michigan |
| Jason S. Knight | grad student | 2005 | University of Michigan |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Torne AS, Robertson ES. (2024) Epigenetic Mechanisms in Latent Epstein-Barr Virus Infection and Associated Cancers. Cancers. 16 |
| Yu H, Robertson ES. (2023) Epstein-Barr Virus History and Pathogenesis. Viruses. 15 |
| Ma N, Lu J, Pei Y, et al. (2022) Transcriptome reprogramming of Epstein-Barr virus infected epithelial and B cells reveals distinct host-virus interaction profiles. Cell Death & Disease. 13: 894 |
| Pei Y, Robertson ES. (2022) The Central Role of the Ubiquitin-Proteasome System in EBV-Mediated Oncogenesis. Cancers. 14 |
| Liu X, Gan J, Du S, et al. (2021) Proteomic Profiling Identifies Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Encoded LANA-Associated Proteins in Hypoxia. Msystems. e0110921 |
| Singh RK, Pei Y, Bose D, et al. (2021) KSHV-encoded vCyclin can modulate HIF1α levels to promote DNA replication in hypoxia. Elife. 10 |
| Knight JS, Lan K, Subramanian C, et al. (2021) Correction for Knight et al., "Epstein-Barr Virus Nuclear Antigen 3C Recruits Histone Deacetylase Activity and Associates with the Corepressors mSin3A and NCoR in Human B-Cell Lines". Journal of Virology. 95: e0076521 |
| Singh RK, Bose D, Robertson ES. (2021) HIF1α regulated expression of the fatty acid binding protein family is important for hypoxic reactivation of KSHV. Journal of Virology |
| Talotta R, Robertson E. (2020) Autoimmunity as the comet tail of COVID-19 pandemic. World Journal of Clinical Cases. 8: 3621-3644 |
| Pei Y, Wong JHY, Robertson ES. (2020) Targeted Therapies for Epstein-Barr Virus-Associated Lymphomas. Cancers. 12 |